Minakem Generic APIs Minakem Generic APIs

X

Digital content for Genentech

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Genentech
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
1 DNA Way, South San Francisco, CA 94080
Telephone
Telephone
+1-650-225-1000, +1 (800) 626-3553
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.globenewswire.com/news-release/2024/06/25/2903709/34825/en/New-Study-From-Inovalon-and-Genentech-Finds-Racial-Disparities-In-Emergency-Department-Visits-For-Liver-Cancer-Care.html

GLOBENEWSWIRE
25 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761053

FDA
21 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761388

FDA
20 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103792

FDA
18 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761106

FDA
18 Jun 2024

https://www.businesswire.com/news/home/20240615264641/en

BUSINESSWIRE
14 Jun 2024

https://www.fiercebiotech.com/cro/digital-medicine-society-partners-pharma-giants-new-digital-endpoints-project

Helen Floersh FIERCE BIOTECH
12 Jun 2024

https://pharmaphorum.com/news/italy-starts-probe-lucentis-biosimilar-delay-allegation

Phil Taylor PHARMAPHORUM
08 Jun 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-others-face-italy-antitrust-probe-over-eye-drug-2024-06-06/

REUTERS
07 Jun 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-5-2024-58484.pdf

FDA
05 Jun 2024
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY